🇺🇸 FDA
Patent

US 11013787

Sustained release formulation of interleukin-10 for wound treatment and related methods

granted A61KA61K38/2066A61K47/10

Quick answer

US patent 11013787 (Sustained release formulation of interleukin-10 for wound treatment and related methods) held by THE REGENTS OF THE UNIVERSITY OF COLORADO FOR AND ON BEHALF OF THE UNIVERSITY OF COLORADO DENVER expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF COLORADO FOR AND ON BEHALF OF THE UNIVERSITY OF COLORADO DENVER
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/2066, A61K47/10, A61K47/36, A61K47/42